New Tech Guru
Sam Whitaker Joins Bracket as Chief Technology Officer
On September. 13, Bracket, a clinical trial technology and specialty services provider based in Wayne, Pennsylvania, announced the hiring of Sam Whitaker as chief technology officer (CTO). Whitaker’s responsibilities will include global product strategy, management and innovation, technology development and engineering, including architecture, user experience (UX), user interface (UI) and IT support functions.
According to a press release, Whitaker has had ten years of experience in clinical technology and global infrastructure innovation. He “will leverage his ten years' experience as co-founder and CEO of Greenphire, the first clinical technology to bring payment technology to the clinical environment,” the company said. Whitaker, a graduate of the University of Pennsylvania, also worked in the product division of Citigroup, designing technology solutions across vertical markets.
While he was at Greenphire, Whitaker invented and successfully commercialized the first clinical trial payment technologies. He and his team built the web-based applications on top of a global technology infrastructure, which was designed to support the unique needs of sponsors, clinical research organizations (CROs) and sites and scaled to support more than 500 clients globally.
According to Jeff Kinell, chief executive officer of Bracket, "Sam Whitaker joins Bracket with highly specific knowledge of clinical trial technology and a complete understanding of our technological vision. As we continue to solidify our position as a global leader in clinical trial technology and specialty services, it's imperative that we partner with our industry's most innovative minds to lead and implement industry-wide advancements."
Bracket, which has nine offices and more than 700 employees worldwide, seeks to enable biopharmaceutical sponsors and contract research organizations to expand the value of their clinical research data by leveraging core competencies in science, technology and service. The company has developed a number of solutions with a unique perspective on clinical research development. The objective is to help clients achieve greater certainty and accurate outcomes in their clinical trials.
Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. It collects information from patients (ePRO), clinicians (eClinRO) and other observers (eObsRO).
Bracket RTSM™ is a scalable and configurable clinical IRT solution for the life sciences industry. It is a single build, multi-modalities deployment supporting traditional IVRS, IWRS and first-in-industry Interactive Mobile Response System (IMRS).
Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. These tools provide subjective methods of collecting research data rely on interpretation by individual research professionals.
Bracket’s mobile App for iOS and Android is a native, dedicated app that enables fully functional screening, randomization, drug dispensation and barcode scanning from a smartphone. Fully secure, Bracket RTSM Mobile App reduces errors in drug dispensation, and streamlines site activities. It is paired with the Bracket Analytics Mobile App, providing quick, portable views of a Bracket RTSM study’s key performance indicators.
Bracket was created in 2011 through the merger of the Specialty Clinical Services and Clinical Technologies Group business units within United BioSource Corporation (UBC). Bracket is no longer owned by UBC and is an independent business.